MBrace Therapeutics
PrivateLast Round
Series B
Nov 14, 2023
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MBrace Therapeutics is a biotechnology company that develops antibody-drug conjugates (ADCs) to treat cancer using its proprietary SPARTA technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MBrace Therapeutics Comparables
Compare MBrace Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 91% | |
| Aarvik Therapeutics | 89% | |
| Mythic Therapeutics | 89% | |
MBrace Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 14, 2023 | ||||
| Series A | Nov 1, 2021 | ||||
| Series A | Oct 1, 2021 | ||||
| Seed | Jun 1, 2020 |
Key People
Founding team and executive leadership
MBrace Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TD Securities | Series B |
| Blue Owl Capital | Series B |
| Avidity Partners | Series B |
| Venrock | Series A, Series B |
| TPG | Series B |
| Alta Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 35% MoM.
- May 17, 2026
Monthly visitors increased 68% MoM.
MBrace Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MBrace Therapeutics's valuation, stock price, and market status.